Melanoma subtypes demonstrate distinct PD-L1 expression profiles-Reference-Cited by-同舟云学术

Melanoma subtypes demonstrate distinct PD-L1 expression profiles

Published:2017-07-24 Issue:9 Volume:97 Page:1063-1071
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Kaunitz Genevieve J,Cottrell Tricia R,Lilo Mohammed,Muthappan Valliammai,Esandrio Jessica,Berry Sneha,Xu Haiying,Ogurtsova Aleksandra,Anders Robert A,Fischer Alexander H,Kraft Stefan,Gerstenblith Meg R,Thompson Cheryl L,Honda Kord,Cuda Jonathan D,Eberhart Charles G,Handa James T,Lipson Evan J,Taube Janis M

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest201764.pdf

Reference56 articles.

1. Sunshine J, Taube JM . PD-1/PD-L1 inhibitors. Curr Opin Pharmacol 2015;23:32–38.

2. Daud AI, Wolchok JD, Robert C et al. Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma. J Clin Oncol 2016;34:4102–4109.

3. Madore J, Vilain RE, Menzies AM et al. PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials. Pigment Cell Melanoma Res 2015;28:245–253.

4. Obeid JM, Erdag G, Smolkin ME et al. PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome. Oncoimmunology 2016;5:e1235107.

5. Taube JM, Anders RA, Young GD et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 2012;4:127ra137.

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological features, response patterns, outcomes and BRAF status in patients with advanced acral melanoma: a preliminary Peruvian study;ecancermedicalscience;2024-08-27

2. Exploring the landscape of urinary tract melanomas: A review for pathologists and clinicians;Urologia Journal;2024-07-24

3. Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study;Cancers;2024-06-27

4. Innovations in Rare Gynecologic Cancer: Melanoma, Neuroendocrine, and Low-Grade Serous Ovarian;American Society of Clinical Oncology Educational Book;2024-06

5. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications;Cancer Research Communications;2024-05-28